Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines

Panov, Alexander V., Gutekunst, Claire-Anne, Leavitt, Blair R., Hayden, Michael R., Burke, James R., Strittmatter, Warren J., Greenamyre, J. Timothy·2002·Nature Neuroscience

DOI 10.1038/nn884

Cited by (1,000)

Items 201–300 of 1,000

Role of calpain in apoptosis.
Hamid Reza Momeni · 2011 · Europe PMC (PubMed Central)
Ethyl-EPA in Huntington disease
Basant K. Puri, Blair R. Leavitt, Michael R. Hayden, Christopher A. Ross, Adam Rosenblatt, J. Timothy Greenamyre, Steven M. Hersch, Krishna S. Vaddadi, A Sword, David F. Horrobin et al. · 2005 · Neurology
Old Things New View: Ascorbic Acid Protects the Brain in Neurodegenerative Disorders
Adriana Covarrubias‐Pinto, Aníbal I. Acuña, Felipe A. Beltrán, Leandro Torres-Díaz, Maite A. Castro · 2015 · International Journal of Molecular Sciences
Mitochondrial-Dependent Ca 2+ Handling in Huntington's Disease Striatal Cells: Effect of Histone Deacetylase Inhibitors
Jorge M. A. Oliveira, Sylvia Chen, Sandra Almeida, Rebeccah R. Riley, Jorge Gonçalves, Catarina Resende Oliveira, Michael R. Hayden, David G. Nicholls, Lisa Ellerby, Ana Cristina Rego · 2006 · Journal of Neuroscience
Mitochondrial dysfunction, oxidative stress, regulation of exocytosis and their relevance to neurodegenerative diseases
Damien J. Keating · 2007 · Journal of Neurochemistry
Insulin and IGF-1 improve mitochondrial function in a PI-3K/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington’s disease knock-in striatal cells
Márcio Ribeiro, Tatiana Rosado Rosenstock, Ana M. Oliveira, Catarina Resende Oliveira, Ana Cristina Rego · 2014 · Free Radical Biology and Medicine
Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases
Rajnish Kumar Chaturvedi, M. Flint Beal · 2012 · Molecular and Cellular Neuroscience
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease
Andrew J. McGarry, Michael McDermott, Karl D. Kieburtz, Elisabeth A. de Blieck, Flint M. Beal, Karen S. Marder, Christopher A. Ross, Ira Shoulson, Peter R. Gilbert, William M. Mallonee et al. · 2016 · Neurology
Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington’s disease
Xiao‐Hong Lu, Virginia B. Mattis, Nan Wang, Ismael Al‐Ramahi, Nick van den Berg, Silvina A. Fratantoni, Henry John Waldvogel, Erin R. Greiner, Alex Osmand, Karla Elzein Merz et al. · 2014 · Science Translational Medicine
Cytotoxicity of a mutant huntingtin fragment in yeast involves early alterations in mitochondrial OXPHOS complexes II and III
Asun Solans, Andrea Zambrano, Mayra Rodríguez, Antoni Barrientos · 2006 · Human Molecular Genetics
Enhanced Akt Signaling Is an Early Pro-survival Response That Reflects N-Methyl-D-aspartate Receptor Activation in Huntington's Disease Knock-in Striatal Cells
Sílvia Ginés, Elena V. Ivanova, Ihnsik Seong, Carlos A. Saura, Marcy E. MacDonald · 2003 · Journal of Biological Chemistry
Mitochondrial dysfunction in Huntington’s disease: the bioenergetics of isolated and in situ mitochondria from transgenic mice
Jorge M. A. Oliveira, Mika B. Jekabsons, Sylvia Chen, Amy Lin, Ana Cristina Rego, Jorge Gonçalves, Lisa Ellerby, David G. Nicholls · 2007 · Journal of Neurochemistry
Cardiac dysfunction in the R6/2 mouse model of Huntington’s disease
Michael J. Mihm, Deborah M. Amann, Brandon L. Schanbacher, Ruth A. Altschuld, John Anthony Bauer, Kari R. Hoyt · 2006 · Neurobiology of Disease
Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation
Rajnish Kumar Chaturvedi, Noel Ylagan Calingasan, Lejin Yang, Thomas Hennessey, A. Johri, M. F. Beal · 2010 · Human Molecular Genetics
Comparative Mitochondrial-Based Protective Effects of Resveratrol and Nicotinamide in Huntington’s Disease Models
Luana Naia, Tatiana Rosado Rosenstock, Ana M. Oliveira, Sofia I. Oliveira-Sousa, Gladys L. Caldeira, Catarina Carmo, Mário Laço, Michael R. Hayden, Catarina Resende Oliveira, Ana Cristina Rego · 2016 · Molecular Neurobiology
Mitochondria, autophagy and age-associated neurodegenerative diseases: New insights into a complex interplay
Eirini Lionaki, Maria Markaki, Konstantinos Palikaras, Nektarios Tavernarakis · 2015 · Biochimica et Biophysica Acta (BBA) - Bioenergetics
Inhibition of Calcineurin by FK506 Protects against Polyglutamine-Huntingtin Toxicity through an Increase of Huntingtin Phosphorylation at S421
Raúl Pardo, Emilie Colin, Etienne Régulier, Patrick Aebischer, Nicole Déglon, Sandrine Humbert, Frédéric Saudou · 2006 · Journal of Neuroscience
Selective deficits in the expression of striatal‐enriched mRNAs in Huntington's disease
Paula Desplats, Kristi E. Kass, Tim Gilmartin, Gregg D. Stanwood, Elliott L. Woodward, Steven Robert Head, J. Gregor Sutcliffe, Elizabeth A. Thomas · 2006 · Journal of Neurochemistry
Oligonucleotide therapeutic approaches for Huntington disease
Dinah W.Y. Sah, Neil Aronin M. D · 2011 · Journal of Clinical Investigation
Structure and Topology of the Huntingtin 1–17 Membrane Anchor by a Combined Solution and Solid-State NMR Approach
Matthias Michalek, Evgeniy Sergeevich Salnikov, Burkhard Bechinger · 2013 · Biophysical Journal
S-Nitrosylation of Drp1 links excessive mitochondrial fission to neuronal injury in neurodegeneration
Tomohiro Nakamura, Piotr Cieplak, Dong‐Hyung Cho, Adam Godzik, Stuart A. Lipton · 2010 · Mitochondrion
Phosphorylation of Huntingtin by Cyclin-Dependent Kinase 5 Is Induced by DNA Damage and Regulates Wild-Type and Mutant Huntingtin Toxicity in Neurons
Sandrine L. Anne, Frédéric Saudou, Sandrine Humbert · 2007 · Journal of Neuroscience
PGC-1α, a New Therapeutic Target in Huntington's Disease?
McGill, Jetta K., Beal, M. Flint · 2006 · Cell
Mitochondrial autophagy in neural function, neurodegenerative disease, neuron cell death, and aging
Yakup Batlevi, Albert R. La Spada · 2010 · Neurobiology of Disease
Adenosine receptors and Huntington's disease: implications for pathogenesis and therapeutics
David L Blum, Raphaël Hourez, Marie‐Christine Galas, Patrizia Popoli, Serge N. Schiffmann · 2003 · The Lancet Neurology
The regulation of OXPHOS by extramitochondrial calcium
Frank Norbert Gellerich, Zemfira Z. Gizatullina, Sonata Trumbeckaitė, Huu Phuc Nguyen, Thilo Pallas, Odeta Arandarčikaitė, Stephan Vielhaber, Enn K. Seppet, Frank Striggow · 2010 · Biochimica et Biophysica Acta (BBA) - Bioenergetics
Mitochondrial Ca2+ and neurodegeneration
Tito Calí, Denis Ottolini, Marisa Brini · 2012 · Cell Calcium
rAAV-mediated shRNA ameliorated neuropathology in Huntington disease model mouse
Yoko Machida, Takashi Okada, Masaru Kurosawa, Fumitaka Oyama, Keiya Ozawa, Nobuyuki Nukina · 2006 · Biochemical and Biophysical Research Communications
Mitochondrial dynamics, a key executioner in neurodegenerative diseases
Komal Panchal, Anand Krishna Tiwari · 2018 · Mitochondrion
Pathophysiology of Huntingtonʼs disease: from huntingtin functions to potential treatments
Emmanuel Flamand Roze, Frédéric Saudou, Jocelyne Caboche · 2008 · Current Opinion in Neurology
Rosiglitazone Treatment Prevents Mitochondrial Dysfunction in Mutant Huntingtin-expressing Cells
Rodrigo A. Quintanilla, Youngnam N. Jin, Karen M. Fuenzalida, Miguel Bronfman, Gail V.W. Johnson · 2008 · Journal of Biological Chemistry
Hypoxia‐inducible factor 1: a new hope to counteract neurodegeneration?
Sónia C. Correia, Paula Isabel Moreira · 2009 · Journal of Neurochemistry
In Vivo Calpain/Caspase Cross-talk during 3-Nitropropionic Acid-induced Striatal Degeneration
Nicolas Bizat, Jean‐Michel Hermel, Sandrine Humbert, Carine Jacquard, Christophe Créminon, Carole Escartin, Frédéric Saudou, Stan Krajewski, Philippe Hantraye, Emmanuel Brouillet · 2003 · Journal of Biological Chemistry
A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin
Maria G. Damiano, Elsa Diguet, Carole Malgorn, Marilena D’Aurelio, Laurie Galvan, Fanny Petit, Lucile Ben Haim, Martine Guillermier, Diane Houitte, Noëlle Dufour et al. · 2013 · Human Molecular Genetics
Oxidative stress promotes mutant huntingtin aggregation and mutant huntingtin-dependent cell death by mimicking proteasomal malfunction
Anand Goswami, Priyanka Dikshit, Amit Mishra, Shalaka A. Mulherkar, Nobuyuki Nukina, Nihar Ranjan Jana · 2006 · Biochemical and Biophysical Research Communications
Cystamine increases l ‐cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation
Jonathan H. Fox, David S. Barber, Bhupinder Singh, Birgit Zucker, Mary K. Swindell, Fran Norflus, Rodica Buzescu, Raman Chopra, Robert J. Ferrante, Aleksey G. Kazantsev et al. · 2004 · Journal of Neurochemistry
Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease
Hua Zhang, Qin Li, Rona K. Graham, Elizabeth Slow, Michael R. Hayden, Безпрозванный Илья Борисович · 2008 · Neurobiology of Disease
Contribution of nuclear and extranuclear polyQ to neurological phenotypes in mouse models of Huntington's disease
Caroline Benn, Christian Landles, Li He, Andrew D. Strand, Ben Woodman, Kirupa Sathasivam, Shi-Hua Li, Shabnam Ghazi‐Noori, Emma Hockly, Syed M.N.N. Faruque et al. · 2005 · Human Molecular Genetics
Neuroprotective effects of PPAR ‐γ agonist rosiglitazone in N171‐82Q mouse model of Huntington's disease
Jing Jin, Jennifer Albertz, Zhihong Guo, Qi Peng, Gay L. Rudow, Juan Carlos Troncoso, Christopher A. Ross, Wenzhen Duan · 2013 · Journal of Neurochemistry
Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington disease
Jacqueline Shehadeh, Herman B. Fernandes, Melinda Zeron Mullins, Rona K. Graham, Blair R. Leavitt, Michael R. Hayden, Lynn A. Raymond · 2005 · Neurobiology of Disease
Neuropathogenesis-on-chips for neurodegenerative diseases
Sarnai Amartumur, Huong Mai Nguyen, Thuy Huynh, Testaverde S. Kim, Ran‐Sook Woo, Eungseok Oh, Kyeong Kyu Kim, Luke P. Lee, Chaejeong Heo · 2024 · Nature Communications
Mitochondrial dynamics and quality control in Huntington's disease
Pedro Guedes-Dias, Brígida R. Pinho, Tânia R. Soares, João de Proença, Michael R. Duchen, Jorge M. A. Oliveira · 2015 · Neurobiology of Disease
A Mitochondria-Associated Oxidative Stress Perspective on Huntington’s Disease
Ju Zheng, Joris Winderickx, Vanessa Franssens, Beidong Liu · 2018 · Frontiers in Molecular Neuroscience
Mitochondrial Ca2+ Signaling in Health, Disease and Therapy
Lorenzo Modesti, Alberto Danese, Veronica Angela Maria Vitto, Daniela Ramaccini, Gianluca Aguiari, Roberta Gafà, Giovanni Lanza, Carlotta Giorgi, Paolo Pinton · 2021 · Cells
Mitochondria and reactive oxygen and nitrogen species in neurological disorders and stroke: Therapeutic implications☆
Juan Pedro Bolaños, María Ángeles Moro, Ignacio Lizasoaín, Ángeles Almeida · 2009 · Advanced Drug Delivery Reviews
Nuclear and cytoplasmic huntingtin inclusions exhibit distinct biochemical composition, interactome and ultrastructural properties
Riguet, Nathan, Mahul-Mellier, Anne-Laure, Maharjan, Niran, Burtscher, Johannes, Croisier, Marie, Knott, Graham, Hastings, Janna, Patin, Alice, Reiterer, Veronika, Farhan, Hesso et al. · 2021 · Nature Communications
The Interplay between Ca2+ Signaling Pathways and Neurodegeneration
Rodrigo Portes Ureshino, Adolfo Garcia Erustes, Taysa Bervian Bassani, Patrícia Wachilewski, Gabriel Cicolin Guarache, Ana Carolina Nascimento, Angélica Jardim Costa, Soraya Soubhi Smaili, Gustavo J.S. Pereira · 2019 · International Journal of Molecular Sciences
PGC-1α at the intersection of bioenergetics regulation and neuron function: From Huntington's disease to Parkinson's disease and beyond
Taiji Tsunemi, Albert R. La Spada · 2011 · Progress in Neurobiology
Mitochondrial Sensitivity and Altered Calcium Handling Underlie Enhanced NMDA-Induced Apoptosis in YAC128 Model of Huntington's Disease
Herman B. Fernandes, Kenneth G. Baimbridge, John Church, Michael R. Hayden, Lynn A. Raymond · 2007 · Journal of Neuroscience
A Dual Role of Adenosine A2AReceptors in 3-Nitropropionic Acid-Induced Striatal Lesions: Implications for the Neuroprotective Potential of A2AAntagonists
David L Blum, Marie‐Christine Galas, Annita Pintor, Emmanuel Brouillet, Catherine A. Ledent, Christa Elisabeth Müller, Kadiombo Bantubungi, Mariangela Galluzzo, David Gall, Laëtitia Cuvelier et al. · 2003 · Journal of Neuroscience
Mitochondrial permeability transition pore induces mitochondria injury in Huntington disease
Rodrigo A. Quintanilla, Youngnam N. Jin, Rommy von Bernhardi M., Gail V.W. Johnson · 2013 · Molecular Neurodegeneration
Endoplasmic reticulum–mitochondria signaling in neurons and neurodegenerative diseases
Andrea Markovinović, Jenny Greig, Sandra M. Martín‐Guerrero, Shaakir Salam, Sébastien Paillusson · 2022 · Journal of Cell Science
The powerhouse takes control of the cell: Is the mitochondrial permeability transition a viable therapeutic target against neuronal dysfunction and death?
Irina G. Stavrovskaya, Bruce S. Kristal · 2004 · Free Radical Biology and Medicine
Oxidative Stress, Mitochondrial Dysfunction and the Mitochondria Theory of Aging
Yahui Kong, Sally E. Trabucco, Hong Zhang · 2014 · Interdisciplinary topics in gerontology and geriatrics
The Neurodegenerative Mitochondriopathies
Russell Howard Swerdlow · 2009 · Journal of Alzheimer s Disease
Gastrointestinal dysfunction contributes to weight loss in Huntington's disease mice
Jorien M.M. van der Burg, Annika Winqvist, N. Ahmad Aziz, Marion L. C. Maat–Schieman, Raymund A.C. Roos, Gillian P. Bates, Patrik Brundin, Maria Björkqvist, Nils Wierup · 2011 · Neurobiology of Disease
Huntington and its Role in Neuronal Degeneration
Shihua Li, Xiao‐Jiang Li · 2004 · The Neuroscientist
Functions, dysfunctions and possible therapeutic relevance of adenosine A2A receptors in Huntington's disease
Patrizia Popoli, David L Blum, Alberto Martire, Catherine A. Ledent, Stefania Ceruti, Maria P. Abbracchio · 2007 · Progress in Neurobiology
Role of NR2B-type NMDA receptors in selective neurodegeneration in Huntington disease
L Li · 2003 · Neurobiology of Aging
Proteome analysis of soluble nuclear proteins reveals that HMGB1/2 suppress genotoxic stress in polyglutamine diseases
Mei‐Ling Qi, Kazuhiko Tagawa, Yasushi Enokido, Natsue Yoshimura, Yo-ichi Wada, Kei Watase, Shoichi Ishiura, Ichiro Kanazawa, Juan Botas, Minoru Saitoe et al. · 2007 · Nature Cell Biology
Multimodal Imaging of Optic Disc Drusen
Taku Sato, Sarah Mrejen, Richard F. Spaide · 2013 · American Journal of Ophthalmology
Apoptosis: A Key in Neurodegenerative Disorders
Oleksandr Y. Ekshyyan, Tak Yee Aw · 2004 · Current Neurovascular Research
Ca2+ signalling in mitochondria: mechanism and role in physiology and pathology
Marisa Brini · 2003 · Cell Calcium
Redox regulation of mitochondrial fission, protein misfolding, synaptic damage, and neuronal cell death: potential implications for Alzheimer’s and Parkinson’s diseases
Tomohiro Nakamura, Stuart A. Lipton · 2010 · APOPTOSIS
Enhanced Striatal NR2B-Containing N -Methyl- d -Aspartate Receptor-Mediated Synaptic Currents in a Mouse Model of Huntington Disease
Lijun Li, Timothy H. Murphy, Michael R. Hayden, Lynn A. Raymond · 2004 · Journal of Neurophysiology
Increased mitochondrial fission and neuronal dysfunction in Huntington's disease: implications for molecular inhibitors of excessive mitochondrial fission
P. Hemachandra Reddy · 2014 · Drug Discovery Today
Mitochondrial Ca2+ in neurodegenerative disorders
Rosella Abeti, Andrey Y. Abramov · 2015 · Pharmacological Research
Interaction of misfolded proteins and mitochondria in neurodegenerative disorders
Andrey Y. Abramov, Alexey V. Berezhnov, Evgeniya I. Fedotova, В. П. Зинченко, Л. П. Долгачева · 2017 · Biochemical Society Transactions
Quality Control in Neurons: Mitophagy and Other Selective Autophagy Mechanisms
Chantell S. Evans, Erika L.F. Holzbaur · 2019 · Journal of Molecular Biology
Membrane Interactions of the Amphipathic Amino Terminus of Huntingtin
Matthias Michalek, Evgeniy Sergeevich Salnikov, Sebastiaan Werten, Burkhard Bechinger · 2013 · Biochemistry
2,4 Dinitrophenol as Medicine
Geisler, John G. · 2019 · Cells
Huntington Disease and the Huntingtin Protein
Zhiqiang Zheng, Marc I. Diamond · 2012 · Progress in molecular biology and translational science
S-Nitrosylation of Critical Protein Thiols Mediates Protein Misfolding and Mitochondrial Dysfunction in Neurodegenerative Diseases
Tomohiro Nakamura, Stuart A. Lipton · 2010 · Antioxidants and Redox Signaling
In Vitro and in Vivo Aggregation of a Fragment of Huntingtin Protein Directly Causes Free Radical Production
Sarah L. Hands, Mohammad U. Sajjad, Michael J. Newton, Andreas Wyttenbach · 2011 · Journal of Biological Chemistry
The contribution of mitochondria to common disorders
Gregory M. Enns · 2003 · Molecular Genetics and Metabolism
Mitochondrial Dysfunction in Huntington’s Disease; Interplay Between HSF1, p53 and PGC-1α Transcription Factors
Taylor A. Intihar, Elisa A. Martinez, Rocío Gómez‐Pastor · 2019 · Frontiers in Cellular Neuroscience
Current progress of mitochondrial transplantation that promotes neuronal regeneration
Chu-Yuan Chang, Min-Zong Liang, Linyi Chen · 2019 · Translational Neurodegeneration
Age‐Dependent Changes in the Calcium Sensitivity of Striatal Mitochondria in Mouse Models of Huntington's Disease
Nickolay Brustovetsky, R. LaFrance, Kevin J. Purl, Tatiana Brustovetsky, Christopher Dirk Keene, Walter C. Low, J M Dubinsky · 2005 · Journal of Neurochemistry
Transcriptional modulator H2A histone family, member Y ( H2AFY ) marks Huntington disease activity in man and mouse
Yi Hu, Vanita Chopra, Raman Chopra, Joseph J. Locascio, Zhixiang Liao, Hongliu Ding, Bin Zheng, Wayne R. Matson, Robert J. Ferrante, Herminia Diana Rosas et al. · 2011 · Proceedings of the National Academy of Sciences
Neurological disorders and mitochondria
João Victor Cabral‐Costa, Alicia Juliana Kowaltowski · 2019 · Molecular Aspects of Medicine
Huntington's Disease
Marcy E. MacDonald, Sílvia Ginés, James F. Gusella, Vanessa Chantal Wheeler · 2003 · NeuroMolecular Medicine
PPARgamma rescue of the mitochondrial dysfunction in Huntington's disease
Ming‐Chang Chiang, Yijuang Chern, Rong Huang · 2011 · Neurobiology of Disease
Protein transamidation by transglutaminase 2 in cells: a disputed Ca 2+ ‐dependent action of a multifunctional protein
Róbert Király, Máté Ágoston Demény, László Fésüs · 2011 · FEBS Journal
Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: Novel therapeutic strategies for neurodegenerative disorders
Dénes Zádori, Péter Klivènyi, Levente Szalárdy, Ferenc Fülöp, József Toldi, László Vécsei · 2012 · Journal of the Neurological Sciences
When calcium goes wrong: genetic alterations of a ubiquitous signaling route
Rosario Rizzuto, Tullio Pozzan · 2003 · Nature Genetics
Oxidative Stress and Altered Mitochondrial Function in Neurodegenerative Diseases: Lessons From Mouse Models
José Carlos Fernández-Checa, A. Fernandez, Albert Morales, Montserrat Marı́, Carmen García‐Ruiz, Anna Colell · 2010 · CNS & Neurological Disorders - Drug Targets
DNA damage induced by polyglutamine-expanded proteins
P. Giuliano · 2003 · Human Molecular Genetics
Severe ultrastructural mitochondrial changes in lymphoblasts homozygous for Huntington disease mutation
Ferdinando Squitieri, Milena Cannella, Gianluca Sgarbi, Vittorio Maglione, Alessandra Falleni, Paola Lenzi, Alessandra Baracca, Giuliana Cislaghi, Carsten Saft C, Giuseppe Ragona et al. · 2005 · Mechanisms of Ageing and Development
Probing Mechanisms That Underlie Human Neurodegenerative Diseases in Drosophila
Manish Jaiswal, Héctor Sandoval, Ke Zhang, Vafa Bayat, Hugo Jozef Bellen · 2012 · Annual Review of Genetics
Dysregulation of Gene Expression in Primary Neuron Models of Huntington's Disease Shows That Polyglutamine-Related Effects on the Striatal Transcriptome May Not Be Dependent on Brain Circuitry
Heike Runne, Etienne Régulier, Alexandre Kuhn, Diana Zala, Özgün Gökçe, Valérie Perrin, Beate Sick, Patrick Aebischer, Nicole Déglon, Ruth Luthi‐Carter · 2008 · Journal of Neuroscience
D-β-Hydroxybutyrate Is Protective in Mouse Models of Huntington's Disease
Soyeon Lim, Adrianne S. Chesser, Jonathan C. Grima, Phillip M. Rappold, David L Blum, Serge Przedborski, Kim Tieu · 2011 · PLoS ONE
Reappraisal of metabolic dysfunction in neurodegeneration: Focus on mitochondrial function and calcium signaling
Pooja Jadiya, Joanne F. Garbincius, John W. Elrod · 2021 · Acta Neuropathologica Communications
P38 MAPK is involved in enhanced NMDA receptor-dependent excitotoxicity in YAC transgenic mouse model of Huntington disease
Jing Fan, Clare M. Gladding, Liang Wang, Lily Y. J. Zhang, Alexandra M. Kaufman, Austen J. Milnerwood, Lynn A. Raymond · 2011 · Neurobiology of Disease
A peptide containing residues 26–44 of tau protein impairs mitochondrial oxidative phosphorylation acting at the level of the adenine nucleotide translocator
Anna Atlante, Giuseppina Amadoro, Antonella Bobba, Lidia de BARI, Veronica Corsetti, Giuseppe Pappalardo, Ersilia Marra, Pietro Calissano, Salvatore Passarella · 2008 · Biochimica et Biophysica Acta (BBA) - Bioenergetics
Striatal cells from mutant huntingtin knock-in mice are selectively vulnerable to mitochondrial complex II inhibitor-induced cell death through a non-apoptotic pathway
Qingguo Ruan · 2004 · Human Molecular Genetics
Striatal synaptic dysfunction and altered calcium regulation in Huntington disease
Lynn A. Raymond · 2016 · Biochemical and Biophysical Research Communications
Ca2+-induced permeability transition in human lymphoblastoid cell mitochondria from normal and Huntington?s disease individuals
Alexander V. Panov, Serena A. Lund, J. Timothy Greenamyre · 2005 · Molecular and Cellular Biochemistry
Dysregulation of Mitochondrial Calcium Signaling and Superoxide Flashes Cause Mitochondrial Genomic DNA Damage in Huntington Disease
Jiuqiang Wang, Qian Chen, Xianhua Wang, Qiao-Chu Wang, Yun Wang, Heping Cheng, Caixia Guo, Qinmiao Sun, Quan Chen, Tie-Shan Tang · 2012 · Journal of Biological Chemistry
Metabotropic Glutamate Receptor-Mediated Cell Signaling Pathways Are Altered in a Mouse Model of Huntington's Disease
Fabiola Mara Ribeiro, Maryse Paquet, Lucimar T. Ferreira, Tamara Cregan, Patrick Swan, Sean P. Cregan, Stephen S. G. Ferguson · 2010 · Journal of Neuroscience
Activated microglia proliferate at neurites of mutant huntingtin-expressing neurons
Andrew David Kraft, Linda S. Kaltenbach, Donald C. Lo, Gaylia Jean Harry · 2011 · Neurobiology of Aging